All lobbying filings
SL Strategies, LLC
SL Strategies, LLC filed a Q2 report for Partner Therapeutics on July 22, 2025, reporting $45,000 in lobbying income.
Lobbying for Partner Therapeutics · biotechnology company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 22, 2025
Income
$45,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
MARY MOODY JOHNSONPreviously held: U.S. Senate Committee on Health, Education, Labor and Pensions
Government bodies contacted
2
Lobbying activity
2
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Fiscal Year 2026 HHS appropriations for rad/nuc preparedness and response, specifically within BARDA and the Strategic National Stockpile.